A study of the calcium complex of a glucosylceramide, soya-cerebroside II

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 12, 2007, Pages 1758-1761

  Kurosu, Michio ^a   Katayama, Seiji ^b   Shibuya, Hirotaka ^c   Kitagawa, Isao ^b  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Calcium ion binding affinity; Calcium ion chelator; Continuous variation method; Endogenous ionophore; Sphingoglycolipid

Indexed keywords

CALCIUM DERIVATIVE; CALCIUM ION; GLUCOSYLCERAMIDE; O (3,6 DIDEOXY BETA DEXTRO GLUCOPYRANOSYL) (1-1) 2 (2' HYDROXYACTANAMIDO) OCT 4 ENE 1 OL; O (BETA DEXTRO GLUCOPYRANOSYL) (1-1) 2 (2' HYDROXYACTANAMIDO) OCT 4 ENE 1 OL; SOYA CEREBROSIDE 2; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM BINDING; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CHELATION; CHEMICAL STRUCTURE; ENDOPLASMIC RETICULUM; PROTON NUCLEAR MAGNETIC RESONANCE; SOYBEAN;

CERAMIDES; CEREBROSIDES; CHELATING AGENTS; GLUCOSYLCERAMIDES; IONTOPHORESIS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 36849013922     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.1758     Document Type: Article

References (37)

1. Degroote S., Wolthoorn J., van Meer G., Seminars in Cell & Develp. Biol., 15, 375-387 (2004) and references therein.
2. Pelled D., Trajkovic-Bodennec S., Lloyd-Evans E., Sidransky E., Schiffmann R., Futerman A. H., Neurobiol. Disease, 18, 83-88 (2005).
3. Aharon-Peretz J., Rosenbaum H., Gershoni-Baruch R., N. Engl. J. Med., 351, 1972-1975 (2004).
4. Lloyd-Evans E., Pelled D., Riebeling C., Futerman H., J. Biochem. (Tokyo), 375, 561-565 (2003).
5. Ramonet D., Pugliese M., Rodriguez M. J., de Yebra L., Andrade C., Adroer R., Ribalta T., Mascort J., Mathy N., J. Physiol. (Paris), 96, 307-312 (2002).
6. Cooper E. C., Jan L. Y., Proc. Natl. Acad. Sci. U.S.A., 96, 4759-4766 (1999).
7. Tymianski M., Clin. Exp. Pharmacol. Physiol., 22, 299-300 (1995).
8. Brady R. O., Kanfer J. N., Shapiro D., Biochem. Biophys. Res. Commun., 18, 221-225 (1965).
9. Hisaki H., Shimasaki H., Ueta N., Kubota M., Nakane M., Nakagomi T., Tamura A., Masuda H., Brain Res., 1171, 73-77 (2004).
10. Denda M., Tomitaka A., Akamatsu H., Matsunaga K., J. Invest. Dematol., 121, 1557-1558 (2003).
11. Nilsson O., Svennerholm L., J. Neurochem., 39, 709-718 (1982).
12. Sieghart W., Schlman H., Greengard P., J. Neurochem., 34, 548-553 (1980).
13. Thorone R. F., Mhaidat N. M., Ralston K. J., Burns G. F., Biochem. Biophys. Res. Commun., 356, 306-311 (2007).
14. Sohn H., Kim Y.-S., Kim H.-T., Kim C.-H., Cho E. W., Kang H. Y., Kim N.-S., Kim C.-H., Ryu E., Lee J. H., Ko J. H., FASEB J., 20, 1248-1250 (2006).
15. Yanagihara K., Kato E., Hitomi S., Sunamoto J., Wada H., Glycoconjugate J., 16, 59-65 (1999).
16. Doherty P., Ashton S. V., Skaper S. D., Leon A., Walsh F. S., J. Cell Biol., 117 1093-1099 (1992).
17. Leskawa K. C., Erwin R. E., Leon A., Toffano G., Hogan E. L., Neurochem. Res., 14, 547-555 (1989) and references therein.
18. Mata A. M., Sepúlveda R., Brain Res. Rev., 49, 398-405 (2005).
19. Lloyd-Evans E., Pelled D., Riebeling C., Bodennec J., de-Morgan A., Waller H., Schffmann R., Futerman A. H., J. Biol. Chem., 278, 23594-23599 (2003).
20. Lloyd-Evans E., Korkotian E., Schwarz A., Pelled D., Schwarzmann G., Segal M., Futerman A. H., J. Biol. Chem., 274, 21673-21678 (1999).
21. Verkhratsky A., Physiol. Rev., 85, 201-279 (2005).
22. Koshy K. M., Wang J., Boggs J. M., Biophys. J., 77, 306-318 (1999).
23. Shibuya H., Kurosu M., Minagawa K., Katayama S., Kitagawa I., Chem. Pharm. Bull., 41, 1534-1544 (1993).
24. For studies on complexes of carbohydrates with metal cations, see: Angyal S. Y., Aust. J. Chem., 25, 1957-1966 (1972).
25. 1 chair conformation. Thus, the C4″-OH in the designed molecule was retained.
26. Kurosu M., Kitagawa I., J. Carbohydr. Chem., 25, 427-439 (2006).
27. The detailed syntheses of 6 will be reported elsewhere.
28. 2+ were ca. 0.01 M.
29. Karplus M., J. Am. Chem. Soc., 85, 2870-2871 (1963). see a web site: http://www.jonathanpmiller.com/Karplus.html.
30. Valéria A., Simionate C., Delmar M., Cantú M. D., Carrilho E., Microchem. J., 82, 214-219 (2006) and references therein.
31. Salmon D. M., Honyman T. W., Nature (London), 284, 344-345 (1980).
32. Sherharn C., Anderson P., Goodman E., Dunharm P., Weissman G., J. Biol. Chem., 256, 2736-2741 (1981).
33. Tyson C. A., Zande H. V., Green D. E., J. Biol. Chem., 251, 1326-1332 (1976).
34. Shibuya H., Kawashima K., Sakagami H., Kawanishi M., Shimomura K., Ohfashi I., Kitagawa I., Chem. Pharm. Bull., 38, 2933-2938 (1990).
35. Kitagawa I., Ohashi K., Koyama W., Kawanishi H., Yamamoto T., Nishino T., Shibuya H., Chem. Pharm. Bull., 37, 1416-1418 (1989).
36. Kitagawa I., Ohashi K., Kawanishi H., Shibuya H., Shinkai K., Akedo H., Chem. Pharm. Bull., 37, 1679-1688 (1989).
37. +).